A study for adults living with chronic hives (chronic spontaneous urticaria)
An early-stage study testing whether an investigational epinephrine nasal spray helps ease hive-flare symptoms in people already on hive medication.
What to expect
Screening visit to confirm eligibility
Short run-in period tracking flares
Self-administer the investigational nasal spray during flares
Log symptoms and photos daily in a smartphone app
Scheduled clinic check-ins
You may be a fit if
Age 18–65
Doctor's diagnosis of chronic hives
Moderate-to-severe flares roughly monthly despite medication
On current treatment for at least 6 weeks
Able to use a smartphone app
More about this study
Read the full details, including what taking part involves and answers to common questions, on the study's information page.
Registry details
This study is registered as NCT06927999: see every site, the full eligibility criteria and the official record.
A few quick questions. No obligation, and your answers stay private.